UPDATE - Immucor Announces Health Canada Approval for Echo Lumena™; Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs

World News: . []

NORCROSS, Ga., Jan. 11, 2019 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next generation, fully automated Echoinstrument, , has received approval by Health Canada. Echo Lumena, designed for the small to mid-volume laboratory segment, is Immucor’s fifth generation immunohematology instrument and brings brilliant performance and clearer test results with the smallest benchtop footprint and the fastest type and screen turnaround time on the global market. Together with its fully automated sibling, (currently available in Canada for testing settings), Echo Lumena and NEO offer a total standardized workflow solution for any laboratory. When combined with our innovative data management solution, ImmuLINK, laboratories are able to combine serology and molecular immunohematology results into one view, greatly improving a laboratory’s productivity. “Whether conducting five or 500 type and screens per day, every lab shares a critical goal to accurately pinpoint the best possible compatible blood match for anyone that needs it, when and where they need it. When our automation solution is combined with the sensitivity of technology to identify antibodies sooner than alternative technologies, it truly means laboratorians can be confident in the results they are producing for physicians and their patients,” said Keith Chaitoff, Immucor’s Chief Marketing Officer.

Adds Christie Otis, Vice President of Immucor’s Transfusion Franchise and Global Customer Programs, “Immucor has been innovating transfusion medicine for more than 30 years. We are excited to build on the success of the Echo Lumena launch in the United States and European markets by bringing our latest innovation to Canada. We are confident that Canadian laboratories will benefit from the accuracy, flexibility and performance available in the newest generation of blood bank automation.”

Echo Lumena builds on Immucor’s heritage of blood banking automation leadership and proven technology. The Echo family has been helping small to mid-sized laboratories automate high quality transfusion medicine since 2007 and has a footprint of more than 1,500 placements worldwide. New capabilities for the improved Echo Lumena system include:

Contact: Michele Howard - 770.441.2051

More news and information about Immucor, Inc.

Published By:

Globe Newswire: 22:00 GMT Friday 11th January 2019

Published: .

Search for other references to "update" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us